Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Cancer Chemotherapy and Pharmacology
|
December 24, 2014
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules
P Hamberg, R H J Mathijssen, P de Bruijn, et al.
British Journal of Cancer
|
December 25, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study
P Hamberg, M J Boers-Sonderen, W T A van der Graaf, et al.
Clinical and Translational Science
|
April 4, 2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide
S Bins, L van Doorn, M A Phelps, et al.
Clinical Genitourinary Cancer
|
January 21, 2024
Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy
K van der Zande, R D Tutuhatunewa-Louhanepessy, P Hamberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer
R J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposure
L Binkhorst, T van Gelder, W J Loos, et al.
Clinical Pharmacokinetics
|
January 19, 2026
The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1)
Amy Rieborn, Niels A D Guchelaar, Teun van Gelder, et al.
The Pharmacogenomics Journal
|
September 9, 2015
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics
A J M Nieuweboer, M Smid, A-J M de Graan, et al.
Frontiers in Oncology
|
July 12, 2021
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
I E de Kruijff, A M Sieuwerts, N Beije, et al.
International Journal of Clinical Oncology
|
December 6, 2017
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
Johannes J M Kwakman, G Vink, J H Vestjens, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Cancer Chemotherapy and Pharmacology
|
December 24, 2014
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules
P Hamberg, R H J Mathijssen, P de Bruijn, et al.
British Journal of Cancer
|
December 25, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study
P Hamberg, M J Boers-Sonderen, W T A van der Graaf, et al.
Clinical and Translational Science
|
April 4, 2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide
S Bins, L van Doorn, M A Phelps, et al.
Clinical Genitourinary Cancer
|
January 21, 2024
Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy
K van der Zande, R D Tutuhatunewa-Louhanepessy, P Hamberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer
R J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposure
L Binkhorst, T van Gelder, W J Loos, et al.
Clinical Pharmacokinetics
|
January 19, 2026
The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1)
Amy Rieborn, Niels A D Guchelaar, Teun van Gelder, et al.
The Pharmacogenomics Journal
|
September 9, 2015
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics
A J M Nieuweboer, M Smid, A-J M de Graan, et al.
Frontiers in Oncology
|
July 12, 2021
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
I E de Kruijff, A M Sieuwerts, N Beije, et al.
International Journal of Clinical Oncology
|
December 6, 2017
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
Johannes J M Kwakman, G Vink, J H Vestjens, et al.
Page
of 6